Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Neuromedin beta: P73T polymorphism in overweight and obese subjects

J. Spálová, H. Zamrazilová, J. Vcelák, M. Vanková, P. Lukásová, M. Hill, K. Hlavatá, P. Srámková, M. Fried, B. Aldhoon, M. Kunesová, B. Bendlová, V. Hainer

. 2008 ; 57 (Suppl 1) : S39-S48.
. 2008 ; 57 (Suppl 1) : S39-S48.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NR7800 MZ0 CEP Register
NR7809 MZ0 CEP Register

Neuromedin beta (NMB) is a member of the bombesin-like peptide family expressed in brain, gastrointestinal tract, pancreas, adrenals and adipose tissue. The aim of our study was to compare the frequency of P73T polymorphism in overweight and obese patients (37 men: age 50.6+/-11.7 years, BMI 41.1+/-7.8 kg/m(2); 255 women: age 49.0+/-11.9 years, BMI 37.9+/-6.8 kg/m(2)) with that of healthy normal weight subjects (51 men: age 28.2+/-7.1 years, BMI 22.3+/-2.0 kg/m(2); 104 women: age 29.1+/-9.1 years, BMI 21.5+/-1.9 kg/m(2)) and to investigate the polymorphism's influence on anthropometric, nutritional and psychobehavioral parameters in overweight/obese patients both at the baseline examination and at a control visit carried out 2.5 years later, regardless of the patient s compliance with the weight reduction program. No significant differences in the genotype distribution were demonstrated between normal weight and overweight/obese subjects. Male T allele non-carriers compared to T allele carriers had higher energy (p=0.009), protein (p=0.018) and fat (p=0.002) intakes and hunger score (p=0.015) at the beginning of treatment. Male T allele non-carriers had a more favorable response to weight management at the follow-up, as they exhibited a significant reduction in waist circumference, energy intake and depression score as well as a significant increase in dietary restraint. No significant differences between carriers and non-carriers were demonstrated in women at the baseline examination. Both female T allele carriers and non-carriers demonstrated similar significant changes in nutritional parameters and in restraint score at the follow-up. Nevertheless, only female non-carriers showed a significant decrease in the hunger score.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13034110
003      
CZ-PrNML
005      
20151006120359.0
007      
ta
008      
131021s2008 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.931488 $2 doi
035    __
$a (PubMed)18271693
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Spálová, Jana $u Institute of Endocrinology, Prague, Czech Republic $7 _AN053814
245    10
$a Neuromedin beta: P73T polymorphism in overweight and obese subjects / $c J. Spálová, H. Zamrazilová, J. Vcelák, M. Vanková, P. Lukásová, M. Hill, K. Hlavatá, P. Srámková, M. Fried, B. Aldhoon, M. Kunesová, B. Bendlová, V. Hainer
520    9_
$a Neuromedin beta (NMB) is a member of the bombesin-like peptide family expressed in brain, gastrointestinal tract, pancreas, adrenals and adipose tissue. The aim of our study was to compare the frequency of P73T polymorphism in overweight and obese patients (37 men: age 50.6+/-11.7 years, BMI 41.1+/-7.8 kg/m(2); 255 women: age 49.0+/-11.9 years, BMI 37.9+/-6.8 kg/m(2)) with that of healthy normal weight subjects (51 men: age 28.2+/-7.1 years, BMI 22.3+/-2.0 kg/m(2); 104 women: age 29.1+/-9.1 years, BMI 21.5+/-1.9 kg/m(2)) and to investigate the polymorphism's influence on anthropometric, nutritional and psychobehavioral parameters in overweight/obese patients both at the baseline examination and at a control visit carried out 2.5 years later, regardless of the patient s compliance with the weight reduction program. No significant differences in the genotype distribution were demonstrated between normal weight and overweight/obese subjects. Male T allele non-carriers compared to T allele carriers had higher energy (p=0.009), protein (p=0.018) and fat (p=0.002) intakes and hunger score (p=0.015) at the beginning of treatment. Male T allele non-carriers had a more favorable response to weight management at the follow-up, as they exhibited a significant reduction in waist circumference, energy intake and depression score as well as a significant increase in dietary restraint. No significant differences between carriers and non-carriers were demonstrated in women at the baseline examination. Both female T allele carriers and non-carriers demonstrated similar significant changes in nutritional parameters and in restraint score at the follow-up. Nevertheless, only female non-carriers showed a significant decrease in the hunger score.
650    _2
$a dospělí $7 D000328
650    _2
$a energetický příjem $x genetika $7 D002149
650    _2
$a stravovací zvyklosti $x fyziologie $7 D005247
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a hlad $x fyziologie $7 D006815
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neurokinin B $x analogy a deriváty $x genetika $7 D015287
650    _2
$a obezita $x genetika $7 D009765
650    _2
$a nadváha $x genetika $7 D050177
650    _2
$a adherence pacienta $7 D010349
650    _2
$a pilotní projekty $7 D010865
650    12
$a polymorfismus genetický $7 D011110
650    _2
$a sexuální faktory $7 D012737
650    _2
$a hmotnostní úbytek $x genetika $7 D015431
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zamrazilová, Hana $u Institute of Endocrinology, Prague, Czech Republic $7 xx0092178
700    1_
$a Včelák, Josef, $u Institute of Endocrinology, Prague, Czech Republic $d 1971- $7 xx0107261
700    1_
$a Vaňková, Markéta, $u Institute of Endocrinology, Prague, Czech Republic $d 1974- $7 xx0140642
700    1_
$a Lukášová, Petra $u Institute of Endocrinology, Prague, Czech Republic $7 xx0078664
700    1_
$a Hill, Martin, $u Institute of Endocrinology, Prague, Czech Republic $d 1962- $7 mzk2005304431
700    1_
$a Hlavatá, Karolína, $u Institute of Endocrinology, Prague, Czech Republic $d 1978- $7 xx0059763
700    1_
$a Šrámková, Petra, $u Clinical Centre ISCARE I.V.F., Prague, Czech Republic $d 1970- $7 xx0119617
700    1_
$a Fried, Martin, $u Clinical Centre ISCARE I.V.F., Prague, Czech Republic $d 1956- $7 nlk20030142871
700    1_
$a Aldhoon, Bashar $u Institute of Endocrinology, Prague, Czech Republic; Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0073780
700    1_
$a Kunešová, Marie, $u Institute of Endocrinology, Prague, Czech Republic $d 1951- $7 jn19990209456
700    1_
$a Bendlová, Běla, $u Institute of Endocrinology, Prague, Czech Republic $d 1962- $7 jo20000074069
700    1_
$a Hainer, Vojtěch, $u Institute of Endocrinology, Prague, Czech Republic $d 1944- $7 jn19990209207
773    0_
$w MED00003824 $t Physiological research $x 0862-8408 $g Roč. 57,Suppl 1 (2008), s. S39-S48
773    0_
$t From clinical to molecular endocrinology $x 0862-8408 $g Roč. 57,Suppl 1 (2008), s. S39-S48 $w MED00170142
856    41
$u http://www.biomed.cas.cz/physiolres/archive.htm $y domovská stránka časopisu - plný text volně přístupný = fulltext
910    __
$a ABA008 $b A 4120 $c 266 $y 3 $z 0
990    __
$a 20131021 $b ABA008
991    __
$a 20151006120544 $b ABA008
999    __
$a ok $b bmc $g 998510 $s 832580
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2008 $b 57 $c Suppl 1 $d S39-S48 $i 0862-8408 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2008 $b 57 $c Suppl 1 $d S39-S48 $i 0862-8408 $m From clinical to molecular endocrinology $n $x MED00170142
GRA    __
$a NR7800 $p MZ0
GRA    __
$a NR7809 $p MZ0
LZP    __
$b NLK138 $a Pubmed-20131021

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...